Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,944 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A New Strategy Toward B Cell-Based Cancer Vaccines by Active Immunization With Mimotopes of Immune Checkpoint Inhibitors.
Tobias J, Battin C, De Sousa Linhares A, Lebens M, Baier K, Ambroz K, Drinić M, Högler S, Inic-Kanada A, Garner-Spitzer E, Preusser M, Kenner L, Kundi M, Zielinski CC, Steinberger P, Wiedermann U. Tobias J, et al. Front Immunol. 2020 May 27;11:895. doi: 10.3389/fimmu.2020.00895. eCollection 2020. Front Immunol. 2020. PMID: 32528470 Free PMC article.
Cross-Reactive Effects of Vaccines: Heterologous Immunity between Tetanus and Chlamydia.
Stojanovic M, Lukic I, Marinkovic E, Kovacevic A, Miljkovic R, Tobias J, Schabussova I, Zlatović M, Barisani-Asenbauer T, Wiedermann U, Inic-Kanada A. Stojanovic M, et al. Among authors: tobias j. Vaccines (Basel). 2020 Dec 1;8(4):719. doi: 10.3390/vaccines8040719. Vaccines (Basel). 2020. PMID: 33271962 Free PMC article.
Clinical and Immunologic Responses to a B-Cell Epitope Vaccine in Patients with HER2/neu-Overexpressing Advanced Gastric Cancer-Results from Phase Ib Trial IMU.ACS.001.
Wiedermann U, Garner-Spitzer E, Chao Y, Maglakelidze M, Bulat I, Dechaphunkul A, Arpornwirat W, Charoentum C, Yen CJ, Yau TC, Tanasanvimon S, Maneechavakajorn J, Sookprasert A, Bai LY, Chou WC, Ungtrakul T, Drinic M, Tobias J, Zielinski CC, Chong L, Ede NJ, Marino MT, Good AJ. Wiedermann U, et al. Among authors: tobias j. Clin Cancer Res. 2021 Jul 1;27(13):3649-3660. doi: 10.1158/1078-0432.CCR-20-3742. Epub 2021 Apr 20. Clin Cancer Res. 2021. PMID: 33879458 Clinical Trial.
Emerging targets for anticancer vaccination: PD-1.
Tobias J, Steinberger P, Drinić M, Wiedermann U. Tobias J, et al. ESMO Open. 2021 Oct;6(5):100278. doi: 10.1016/j.esmoop.2021.100278. Epub 2021 Oct 11. ESMO Open. 2021. PMID: 34649221 Free PMC article. Review.
Active immunization with a Her-2/neu-targeting Multi-peptide B cell vaccine prevents lung metastases formation from Her-2/neu breast cancer in a mouse model.
Tobias J, Drinić M, Högler S, Ambroz K, Baier K, Kodajova P, Tomasich E, Berghoff AS, Schmid A, Garner-Spitzer E, Kenner L, Kundi M, Zielinski CC, Wiedermann U. Tobias J, et al. Transl Oncol. 2022 May;19:101378. doi: 10.1016/j.tranon.2022.101378. Epub 2022 Mar 5. Transl Oncol. 2022. PMID: 35259675 Free PMC article.
1,944 results